Latest Innovation News

1414 Degrees has acquired exclusive global rights to a patented silicon nanoparticle technology from George Washington University, aiming to revolutionize lithium-ion battery anodes with higher capacity and faster charging. The company also raised $1.214 million to accelerate commercialisation and OEM engagement starting late 2025.

EVE Health Group has raised $1.1 million to accelerate the commercial rollout of its innovative pharmaceutical products Dyspro and Libbo, signaling strong investor confidence in its growth strategy.

Pathkey.AI’s TrialKey platform continues to validate its AI-driven clinical trial success predictions, with September 2025 seeing an average 43.6% share price increase across flagged biotech stocks.

Immutep Limited has enrolled over 170 patients in its global Phase III TACTI-004 trial for advanced non-small cell lung cancer, surpassing the threshold needed for a futility analysis expected in early 2026.

Guzman y Gomez reports robust Q1 FY26 sales growth and network expansion, alongside a significant $100 million share buyback to enhance shareholder value.

Octava Minerals is set to launch an exploration drilling program at its Byro Critical Minerals Project following impressive bioleaching recoveries of rare earths, lithium, and vanadium. The initiative aims to define a maiden resource and advance the project’s development.

Lithium Universe has bolstered its photovoltaic recycling program by appointing a robotics expert to accelerate silver recovery technology, advancing plans for a Texas recycling facility.

Altech Batteries has achieved a major milestone with its Silumina Anodes™, delivering 88.5% capacity retention after 500 cycles and a 40% capacity boost over graphite anodes. This advancement promises longer electric vehicle ranges and lighter battery packs.

NH3 Clean Energy updates investors on the WAH2 clean ammonia project, highlighting strong market potential, strategic partnerships, and robust project economics as it moves toward a Final Investment Decision.

PainChek Limited has achieved a landmark FDA De Novo classification for its PainChek Adult App, positioning it as the first regulated medical device for pain assessment in the US aged care sector and opening a $100 million annual market opportunity.

Anatara Lifesciences has completed the first tranche of its two-part share placement, issuing over 33 million ordinary shares to professional investors. This move marks a significant step in the company’s capital raising efforts amid ongoing product development.

OpenLearning Limited has raised $2.6 million through a well-supported equity placement to accelerate its global growth and AI-driven product development, targeting new markets like the Philippines and Brazil.